For researchers serious about optimizing their peptide protocols, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, proven protocols, and a community of thousands who have navigated these exact questions
And we're here to help
Unlike TB-500 (Thymosin Beta-4 fragment), which acts primarily via G-actin sequestration and endothelial progenitor cell mobilization, BPC-157 exerts its action via an NO-dependent pathway and VEGFR2 modulation two distinct but potentially complementary mechanisms, which is why research protocols sometimes combine both peptides (synergy documented in animal tendon repair models)
Who Its For Researchers requiring a spray-format delivery vehicle for BPC-157 in mucosal, topical, or intranasal research protocols
Assuming the above, the researcher may administer DSIP via nasal spray as follows: DSIP Dosage: A total daily dose of 300mcg, with 150mcg administered in each nostril in three sprays of 50mcg each, may be applied